Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
60,938.54 -2,043.98 (-3.25%) CMC Crypto 200
1,260.51 -97.50 (-7.18%)
GILD Jan 2025 70.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:16PM EDT. Market open.
| Previous close | 2.9900 |
| Open | 3.2500 |
| Bid | 3.5500 |
| Ask | 3.7000 |
| Strike | 70.00 |
| Expiry date | 2025-01-17 |
| Day's range | 3.2400 - 3.6700 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.07k |
ZacksGilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Business WireKite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
REDWOOD CITY, Calif. & SANTA MONICA, Calif., May 09, 2024--Kite, a Gilead Company (NASDAQ: GILD), and Arcellx, Inc. (NASDAQ: ACLX) today announced several key operational updates on their partnered anitocabtagene autoleucel (anito-cel) multiple myeloma program. Anito-cel is the first BCMA CAR T to be investigated in multiple myeloma that utilizes Arcellx’s novel and compact D-Domain binder.
GuruFocus.comDecoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight
Unraveling the Financial Dynamics and Strategic Directions of Gilead Sciences Inc (GILD)
© 2024 Yahoo. All rights reserved.